Stockscreener 앱 받기
15.67
1.72%
0.1502
전일 마감가:
$15.52
열려 있는:
$15.53
하루 거래량:
196.68K
Relative Volume:
0.20
시가총액:
$765.93M
수익:
-
순이익/손실:
$-695.98M
주가수익비율:
-0.0477
EPS:
-328.6331
순현금흐름:
$-143.65M
1주 성능:
+12.52%
1개월 성능:
-2.97%
6개월 성능:
-16.78%
1년 성능:
+39.76%
1일 변동 폭
$15.51
$16.08
1주일 범위
$13.66
$16.08
52주 변동 폭
$2.622
$65.80
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
500 BOYLSTON STREET, BOSTON
Compare VOR vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
15.68 | 758.11M | 0 | -695.98M | -143.65M | -328.63 |
VRTX
Vertex Pharmaceuticals Inc
|
426.82 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
722.41 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
809.29 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.37 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
311.83 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 개시 | Jefferies | Buy |
| 2026-03-19 | 개시 | Wells Fargo | Overweight |
| 2026-01-09 | 개시 | Citigroup | Buy |
| 2025-12-17 | 개시 | TD Cowen | Buy |
| 2025-12-09 | 개시 | JP Morgan | Overweight |
| 2025-11-25 | 재개 | Wedbush | Neutral |
| 2025-10-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | 업그레이드 | Stifel | Hold → Buy |
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Six new Vor Bio hires get stock awards priced at $13.85 - Stock Titan
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Jefferies Financial Group Upgrades Vor Biopharma (NASDAQ:VOR) to Strong-Buy - MarketBeat
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Down 17.3% in April - MarketBeat
Vor Biopharma (NASDAQ: VOR) files resale registration for 5.34M shares - Stock Titan
Vor Biopharma (NASDAQ: VOR) plans virtual 2026 meeting and equity plan changes - Stock Titan
[ARS] Vor Biopharma Inc. SEC Filing - Stock Titan
Vor Biopharma Shares Skyrocket on Global Licensing Deal for Autoimmune Therapy - MSN
Wall Street analysts predict a 107.82% upside in Vor Biopharma (VOR): Here's what you should know - MSN
Vor Bio announces $75M private placement - MSN
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 165,150 Shares - MarketBeat
Ra capital healthcare fund sells 165,150 Vor Biopharma shares for $2.6m By Investing.com - Investing.com Australia
Ra capital healthcare fund sells 165,150 Vor Biopharma shares for $2.6m - Investing.com UK
RA Capital fund trims Vor Biopharma (NASDAQ: VOR) stake with 165,150-share sale - Stock Titan
VOR shares rally over 40% in pre-market trade after JPMorgan initiates bullish coverage - MSN
Vor Biopharma (VOR) Cost Structure | Q4 2025: EPS Exceeds ExpectationsGDR - Xã Vĩnh Công
Vor Biopharma(VOR.US) 10% Shareholder Sells US$10.17 Million in Common Stock - Moomoo
Ra Capital sells $10.17 million of Vor Biopharma common stock By Investing.com - Investing.com Australia
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Vor Biopharma Inc - GuruFocus
Vor Biopharma (NASDAQ:VOR) Director Sells $7,462,931.08 in Stock - MarketBeat
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 171,963 Shares of Stock - MarketBeat
Ra Capital sells $10.17 million of Vor Biopharma common stock - Investing.com
RA Capital trims Vor Biopharma (VOR) stake, still owns 19.9% - Stock Titan
RA Capital fund trims Vor Biopharma (VOR) stake with 630K-share sale - Stock Titan
Vor Biopharma (NASDAQ:VOR) Shares Down 4.4%Here's What Happened - MarketBeat
Vor Biopharma (VOR) Stock Volume Stability (Drops Sharply) 2026-04-20High Attention Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect? - Yahoo Finance
Vor Biopharma (VOR) Stock: Is It Respecting Levels (Investor Interest) 2026-04-18Index Investing - Cổng thông tin điện tử Tỉnh Sơn La
Vor Biopharma (NASDAQ:VOR) Trading 9.7% HigherWhat's Next? - MarketBeat
Jeremy Brett Sokolove Net Worth (2026) - GuruFocus
Vor Biopharma Q1 EPS Estimate Increased by HC Wainwright - MarketBeat
H.C. Wainwright Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $31 - Moomoo
VOR Forecast, Price Target & Analyst Ratings | VOR BIOPHARMA INC (NASDAQ:VOR) - ChartMill
VOR Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $31 - GuruFocus
Ra Capital Management, L.P. Sells 530,610 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million By Investing.com - Investing.com India
RA Capital sells Vor Biopharma (VOR) shares worth $11.8 million - Investing.com
Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 153,735 Shares of Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Sells $858,840.44 in Stock - MarketBeat
RA Capital reports 19.9% Vor Biopharma (VOR) stake after share sales - Stock Titan
RA Capital entities trim Vor Biopharma (VOR) stake with 738K-share open-market sale - Stock Titan
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
보 바이오파마 주식 (VOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 17 '26 |
Sale |
16.28 |
458,411 |
7,462,931 |
2,739,208 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 20 '26 |
Sale |
15.77 |
171,963 |
2,711,857 |
2,567,245 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 13 '26 |
Sale |
16.15 |
530,610 |
8,569,352 |
3,404,998 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 14 '26 |
Sale |
15.97 |
153,735 |
2,455,148 |
3,251,263 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 15 '26 |
Sale |
16.01 |
53,644 |
858,840 |
3,197,619 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 08 '26 |
Sale |
16.48 |
484,104 |
7,977,786 |
4,071,637 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 09 '26 |
Sale |
16.59 |
135,201 |
2,242,985 |
3,936,436 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 10 '26 |
Sale |
15.75 |
828 |
13,041 |
3,935,608 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 06 '26 |
Sale |
16.59 |
589,257 |
9,777,898 |
4,555,741 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Apr 02 '26 |
Sale |
18.23 |
260,000 |
4,741,066 |
5,144,998 |
0.78%
3.01%
자본화:
|
볼륨(24시간):